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ABSTRACT 
Tympanic membrane perforations are broadly pathological and traumatic in origin. The fibrosed rim of 
perforation and medially migrated epithelial layer of the perforated membrane offers a cauterization 
opportunity which conspicuously breaks the epithelial barrier, dissolves necrosed tissue over growth 
and enhances neo membrane formation. Trichloroacetic acid chemical cautery and patching is used 
from decades in order to reconstitute the tympanic membrane integrity with a successful rate hovering 
around 85-92% in various clinical studies. Nowhere in the classical Ayurveda texts or in the modern 
literature Apamarga Kshara (Achyranthes aspera Linn. alkaline extract) paste cauterization is used for 
re-epithelialization of the tympanic membrane although its tissue generative properties and 
antimicrobial traits are quite well documented. 34 tympanic membrane perforation patients after 
ramifying them into two groups were selected for the present clinical study which intends to compare 
the effectiveness of tympanic membrane perforation closure by application of trichloroacetic acid vis-a-
vis application of Achyranthes aspera alkaline extract on the margins of the perforation. Achyranthes 
aspera alkaline extract for the current clinical trial as a trial drug has its proven tissue regeneration and 
vasoproliferative properties which is an indispensible prerequisite in any attempt to restore the 
integrity of a perforated tympanic membrane, also its antimicrobial and vasoproliferative capacity also 
compliments the selection of Achyranthes aspera alkaline extract. This cauterization with Apamarga 
Kshara was found to be quite effective as the results were encouraging and can successfully be 
advocated as an Ayurvedic cauterization substitute for the resurfacing of the ruptured tympanic 
membrane.  
KEYWORDS: Tympanic membrane, Trichloroacetic acid, Apamarga Kshara, Achyranthes aspera, 
Cauterization, Pure tone audiometery (PTA). 
INTRODUCTION
 Tympanic membrane perforation (TMP) is a 
condition as old as the human species. TMPs can result 
from disease (particularly infection) and trauma. 
Perforations can be temporary or persistent. Effect 
varies with size, location on the drum surface, and 
associated pathologic condition. Infection is the principal 
cause of tympanic membrane perforation (TMP) is 
infection. Acute infection of the middle ear may cause a 
relative ischemia in the drum concurrent with increased 
pressure in the middle ear space. This leads to a rupture 
of the tympanic membrane that is usually preceded by 
severe pain. If the perforation does not heal, it leaves a 
residual tympanic membrane perforation (TMP). 
 Traumatic perforations occur from blows to the 
ear, severe atmospheric overpressure, exposure to 
excessive water pressure (e.g. in scuba divers), and 
improper attempts at wax removal or ear cleaning. 
Traumatic perforations usually heal spontaneously, and 
it is preferable to wait for at least 3 weeks prior to any 
intervention.  
 Perforations result from acute otitis media and 
trauma heal spontaneously in the majority of cases. But if 
there is repeated infections or if the infection is 
persistent, there is less possibility of spontaneous 
healing of these perforations. Long-standing tympanic 
membrane perforations may cause conductive hearing 
loss and middle ear infection even if they are small. 
Although 88% of tympanic membrane perforations of 
any size heal without any interventions, the rest become 
chronic & require surgery. These non-healing 
perforations typically require myringoplasty and 
tympanoplasty for closure. Medical costs associated with 
tympanoplasty have recently compelled investigators to 
search for less expensive, simple non-surgical methods. 
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 The purpose of closure of chronic dry tympanic 
membrane perforations is to restore the continuity of the 
tympanic membrane in order to improve hearing and 
decrease the incidence of middle ear infections. Closure 
isolates the middle ear from external environment and 
prevents contamination by exposure to pathogens and 
restores the vibratory area of the membrane and affords 
round window protection.  
 Closure of these perforations is gratifying to 
both the patient and the surgeon. The patient stands to 
gain as much as 25 db of hearing and in some cases, 
tinnitus gets relieved. Also, the patient gets a discharge 
free ear. During the period from the Seventeenth to the 
Nineteenth century, several methods have been 
attempted at closing the tympanic membrane 
perforation. At first, closure of the perforation was tried 
with a prosthesis. Ivory tube (Banzer 1640), rubber disc 
(Toynbee1853), paper disc (Blake 1887) and various 
other materials were used. In 1876, Roosa used 
cauterising agents to promote the healing of tympanic 
membrane perforations and he used a silver nitrate bead, 
while trichloroacetic acid was first advocated in 1895 by 
Okuneff and it still remains the most popular chemical 
used for this purpose2,3. In 1919 Joynt combined both 
cautery and paper patch technique and Linn used a moist 
cotton ball with repeated cautery at weekly intervals. 
Both these techniques were very effective. The method 
by Linn was modified and popularized by Derlacki and 
Wright in 19534. Trichloroacetic acid with an aluminum 
paper foil patch technique is the control group of the 
present trial as it is a time tested non surgical method for 
the closure of perforation with a non infected middle ear.  
 Throughout the history of traditional medical 
systems, plants have always been used as ingredients in 
most of the treatment therapies. The use of plants in 
traditional health care systems is rooted on the 
exploitation of this biogenic pool of metabolites. 
Achyranthes aspera Linn. is one of the numerous 
medicinal plant species with a remarkable therapeutic 
potential that is commonly recognized as Prickly Chaff 
flower. The species belongs to the Amaranthaceae family 
and is widely distributed as a weed throughout the 
tropical and subtropical regions of the world. The plant is 
popular in folk remedy in traditional systems of medicine 
in tropical Asia and African countries. Its diverse uses in 
the various traditional health care systems include the 
treatment of fever, wound healing, tooth ache, arthritis, 
gynaecological disorders, urinary disorders, insect and 
snake bites, abdominal tumor, stomach pain and a 
number of other ailments5.  
 Phenolic compounds of Achyranthes aspera, have 
been shown to enhance tissue regeneration responsible 
for superficial wounds and burn healing, have 
demonstrated antiseptic effects (antibacterial and 
antifungal) and have antioxidant properties (Bruneton, 
1995). Phenolic-protein complexes have been implicated 
in wound healing. The complexes form a film which 
limits fluid loss and forms a physical barrier to microbial 
infections and forms insulations on damaged tissue 
protecting the wound from chemical harm.6 
 Kshara chikitsa (purified alkaline extract) has 
been in practice since 500 BC. As per Sushruta, the 
Kshara is prepared from 22 plants such as Achyranthus 
aspera, Euphorbia nerifolia, Cassia fistula, Holarrhena 
antidysentrica, Adhatoda vasica, Calotropis giganteo, 
Sesamum indicum etc. There are two types of Kshara 
preparation: one is Paniya Kshara for internal use while 
the other one is the Pratisaraniya Kshara for external 
use. The Pratisaraniya kshara is further divided into 
three types, i.e. Mridu (mild in action), Madhya 
(moderate in action) and Tikshna (strong in action). In 
this study, Tikshna kshara was taken into consideration 
for local application directly on the margins of the 
perforated tympanic membrane. The idea behind 
selection of Achyranthes aspera alkaline extract for the 
current clinical trial as a trial drug has its proven tissue 
regeneration property is an indispensible prerequisite in 
any attempt to restore the integrity of a perforated 
tympanic membrane, also its antimicrobial and 
vasoproliferative capacity also compliments the selection 
of Achyranthes aspera alkaline extract7,8. A. aspera 
treated animals showed collagen deposition, fibroblast 
proliferation and formation of epidermis. A. aspera 
showed significant (p < 0.05) wound healing, which was 
evident by wound contraction, elevation of various 
antioxidant enzymes, catalase, vitamin C and prohealing 
and biochemical parameters like hydroxyproline and 
protein content than the control animals.9,10 Apamarga 
Kshara (Achyranthes aspera alkaline extract) is 
traditionally used for the treatment of hemorrhoid 
treatment but never has been used for the repair of 
tympanic membrane and hence this attempt of closure of 
tympanic membrane perforation by cauterization with 
Apamarga Kshara stands to be a pilot study in every 
sense.  
MATERIALS AND METHODS 
 The present work is randomised, single blind, 
prospective, crossover and single centre study 
comprising patients of either sex in the age group 16-70 
years. This clinical study was carried from June 2009 to 
July 2014. The patients for the research were selected 
from Department of Shalakya Tantra OPD, M.S.M. 
Institute of Ayurveda, B.P.S. Mahila Vishwavidyalaya, 
Khanpur Kalan, Haryana, India. Patients with bilateral or 
unilateral TMP abiding with the inclusion criterion were 
selected for the trial and diagnosed patients satisfying 
inclusion/exclusion and criteria of assessment were 
divided into two trial groups after having written and 
informed consent from the patient to participate in the 
study on a recorded and standardized Performa. The 
patient was also briefed about the research protocol, 
intervention, duration of trial, route of administration of 
drug and possible undesirable effects, prior to the 
consent. An official permission from institution’s 
research ethical committee and hospital core committee 
was also taken before the commencement of the trial 
vide communication letter no. MSM/EC/SKT/2009/11. 
Eustachian tube patency was assessed by Valsalva’s 
Maneuver. An Otoendoscopy/Otomicrosopy was 
performed to measure the size of perforation and to rule 
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out the presence of cholesteatoma, tympanosclerosis, 
large perforation, subtotal perforation, marginal 
perforation and pars flaccid perforation. 
Statistical Analysis 
 The calculations performed for the present 
study was done by spreadsheets developed by Microsoft 
Excel (2007).  
Selection of the patients 
 40 patients were selected for the clinical study 
intends to compare the effectiveness of tympanic 
membrane perforation closure by application of 
trichloroacetic acid vis-a-vis application of Apamarga 
Kshara (Achyranthes aspera alkaline extract) on the 
margins of the perforation for cauterization. Both 
unilateral and bilateral tympanic membrane perforations 
are taken up for the current trial. Six patents were lost in 
the study/drops out perhaps because of multiple 
application and discomfort during the procedure and 
hence a total of 34 patients having participated in the 
current clinical trial. Both pathological and traumatic 
perforations are included in the present trial by 
ramifying them into two underling groups: 
1. Trichloroacetic acid group (TCAG): in this group a 
total of 16 patients were treated for the perforation 
of the tympanic membrane by multiple application of 
50% solution of Trichloroacetic acid as a 
cauterization procedure on tympanic membrane 
margins. Patching with aluminium foil of the treated 
margins was done in order to provide a structured 
support to the newly grown tympanic membrane 
underneath. A time interval of 1 week is observed 
between two application and done as an OPD 
procedure.  
2. Apamarga Kshara group (APKG): in this group a 
total of 18 patients were treated with cauterization 
of the tympanic membrane perforation margins 
repeatedly by multiple application of Apamarga 
Kshara paste. Rest of the procedure including 
patching and after care is same as of TCAG. 
Technique observed in chemical cauterization with 
paper patching in both groups 
 The technique was carried out as an OPD 
procedure. For those who had bilateral perforations, one 
ear was treated first and the other ear was treated 6 
weeks to 3 months later. For the initial application, 4% 
Xylocaine was used to anaesthetize the tympanic 
membrane by adding a few drops into a small cotton ball 
and placing it into the external canal wall over the 
surface of the tympanic membrane for about 10 min, 
while subsequent applications did not require local 
anaesthesia in most of the cases. The rim of the 
perforation was cauterized using cotton tipped 
applicator stroke by stroke dipped in 50% trichloroacetic 
acid until a white cauterized margin 0.5mm in width is 
created and the excess of the chemical was drained using 
a dry cotton swab under the operative microscope. Once 
the blanching of the rim was completed, a small sterile, 
thin aluminium foil impregnated with antibiotic cream 
was placed as a patch over the perforation. The patch 
acts as a splint to bridge the margins of the perforation 
and give flat surface. The patients were evaluated every 1 
week; most of them requiring more than one application 
and the technique was repeated for a maximum of five 
times.  
 In case of Apamarga Kshara application group 
also the same technique is observed to cauterize the 
margins of the perforation although it takes a little more 
time to actually blanch the perforated margin rim in an 
attempt to resurface the tympanic membrane. Patching 
with aluminium foil was done in APKG also to provide a 
buttress, underneath of which the neo tympanic 
membrane is allowed to grow.  
Inclusion criteria 
 Patients with central perforation of tympanic 
membrane following Chronic Suppurative Otitis 
Media or traumatic perforations of tympanic 
membrane. 
 Age group of 16-70 years. 
 At least 2 months old dry perforations were 
included. 
 Central perforations not more than 5 mm (35%) by 
visual assessment were included in the study. 
 Exclusion criteria 
 History of previously done otological surgical 
intervention. 
 Active rhinosinusitis 
 Atticoantral disease 
 Active discharge 
 Nasopharyngeal pathology 
 Eustachian tube dysfunction 
 History of substance abuse and noise induced 
hearing loss 
 Suggestion of other middle disorders existing, if any. 
 Patients hypersensitive to local anaesthetic agent i.e. 
lignocaine. 
 Hearing assessment was done by Tuning fork 
tests and Pure Tone Audiometry (PTA) and an 
audiometric average was calculated in all the patients 
before and after the completion of the trial. Nasal 
Endoscopy was done to rule out any naso- pharyngeal 
pathology, Eustachian tube dysfunction and rhino 
sinusitis etc. 
OBSERVATIONS AND RESULTS 
 Total number of 16 cases and 18 cases were 
registered in the TCAG and APKG respectively. Majority 
of the TCAG were of unilateral perforation and 
pathological/CSOM perforation. APKG group statistical 
observation reflected 13 cases of unilateral perforation 
and 13 cases of pathological/CSOM perforation out of 18 
cases (Column chart 1). Maximum number of patients 
required application 2 and 3 times application of the trial 
drugs in both the groups under trial viz. TCAG and APKG. 
 Average number of application required for the 
closure/resurfacing of the tympanic membrane was 
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found to be 3.07 and 3.26 respectively in TCA and APKG 
(Table 1, 2). Perforation size was < 3 mm in 7 patients of 
TCAG and 8 patients of APKG. Hearing loss in db was 
considered by audiometric average parameter (average 
of 500,100 and 2000 Hz in Pure tone audiometery) and 
found to be 36 db before intervention in TCAG and 38 db 
in APKG. The hearing loss average was reduced to 17 db 
in TCAG and 18 db in APKG (Table 3). 87.5% of the 
perforations were successfully closed in TCAG and 83.3% 
in APKG. 2 patients were having residual perforation on 
TCAG and 3 patients were unable to having resurfacing 
of the tympanic membrane in APKG. All of the traumatic 
perforation healed in both the groups under trial 
(Column chart 2). 
DISCUSSION 
 The Tympanic Membrane (TM) plays a 
significant role in the physiology of hearing as well as in 
the pathophysiology of chronic inflammatory middle ear 
diseases. The tympanic membrane perforations 
significantly impair the quality of life of patients11. A 
tympanic membrane perforation causes conductive 
hearing loss due to loss of ossicular coupling which is 
again due to loss of sound pressure difference across the 
tympanic membrane which provides the primary drive 
to the motion of the drum and ossicles. In addition, 
perforation causes a loss that depends on frequency, 
perforation size and middle ear space. Perforation 
induced losses are greatest at lowest frequencies. The 
volume of middle ear space also affects hearing. Smaller 
volume results in larger airborne gap. For a given sound 
pressure in the ear canal and a given perforation, the 
resulting sound pressure within the middle ear cavity is 
inversely proportional to the middle ear volume. So the 
transtympanic sound pressure difference will be smaller 
with smaller middle ear volumes. Identical perforations 
in two different ears have conductive losses that can 
differ by up to 20–30 db if the middle ear space volumes 
differ. The first recorded use of silver nitrate to stimulate 
closure of tympanic membrane perforations is by 
William Wilde in 184812.  
 The office chemical myringoplasty was 
introduced by Roosa in 1876 and was popularized by 
Derlacki in the 1950s who reported good results and the 
procedure came to be known as the Derlacki method13,14. 
In his method he used trichloroacetic acid to cauterize 
perforation followed by antibiotic sufflation and 
covering with sterile cotton pledgets and prescribing 
Euthymol ear drops. Two decades later, Derlacki 
reported that he and his colleagues (Shambaugh, 
Harrison and Clemis) at Otologic Professional Associates 
at Chicago and cumulatively treated 1277 pars tensa 
perforations between 1953 and 1972 and had 
successfully healed at least 1027 of them (80.4%)15.  
 A large perforation of the tympanic membrane 
heals often into a thin atrophic scar which is devoid of 
the middle fibrous elements that provide structural 
support, having only an outer epidermis and inner 
mucosal layer. Although such a tympanic membrane is 
adequate for the purposes of sound conduction, it is 
vulnerable to repeated perforation by infection or 
eustachian tube dysfunction. The principle of closure by 
promotion of healing of the tympanic membrane 
involves inducing the fibrous layer to close the 
perforation prior to epithelial closure, restoring the 
normal anatomy of the tympanic membrane. 
Histopathological study of a newly formed perforation 
shows proliferation of squamous epithelium within 12 
hours at the edge of the perforation, granulation 
formation within 36 hours16, while the inner mucosa of 
the membrane takes several days to regenerate. As long 
as there is a suitably flat surface, stratified squamous 
epithelium grows at the rate of 1 mm a day17. 
 Histopathological examination of permanent 
perforations showed that stratified squamous epithelium 
grows medially over the edge of the perforation with no 
raw surface, which appears to arrest the subsequent 
closure of the perforation18. Removal of this medialized 
epithelium forms the basis of some of the treatments for 
tympanic membrane perforation. Outer squamous 
epithelium that has grown inward across the edges must 
be destroyed repeatedly by cauterization to permit 
fibroblastic proliferation of the fibrous layer, the rim of 
the perforation should be kept moist as drying 
immediately kills the young fibroblasts, hyperemia 
stimulates fibroblastic proliferation and should be 
induced by mild irritation. 
 The present pilot study intends to evaluate 
Apamarga Kshara properties in tympanic membrane 
regenerative traits as it has traditionally used in wound 
healing and tissue growth. Alkaline preparations of A. 
aspera can be externally used in such skin diseases like 
Psoriasis, Taeniasis, Vitiligo, Non-lepromatous lesion, 
Fistula-in-ano, Tumor, Non-healing ulcer, Sinus, 
Exfoliative dermatitis, Mole, Non-elevated mole, 
Localized hyper pigmentation of skin, Nevus, and 
Abscess and Hemorrhoid. The pharmaceutical study of 
Apamarga Kshara is depicted hereby19. 
Basic chemical traits 
Loss on drying at 110°C: 7.25% w/w 
pH of 5% by pH paper: 10 
Ash value: 67.75% w/w 
Water soluble extractive: 78% w/w 
Organoleptic characters 
Color: Dull white 
Touch: Smooth 
Taste: Alkaline 
Quantitative estimation 
Magnesium: Not 0.092-1.045% w/w 
Sodium: Not <1.000% w/w, not >28.844% w/w 
Potassium: Not <0.05% w/w, not >30.54% w/w 
Chloride: Not <15.09% w/w, not >19.81% w/w 
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Carbonate: Not <13.92% w/w, not >25..583% w/w 
Sulfate: Not <12..4755 w/w, not >21.280 w/w 
Calcium: Not <1.685 w/w, not >3.5185 w/w 
Phosphate: Not <4.211% w/w 
Iron: Not >0.263% w/w 
Moisture: Not >1.414% w/w 
pH value: Not <10.1, not >11.8 
 Cauterization with A. aspera alkaline extract 
breaks the submucosal fibrosis, excessive necrosed 
tissue and augments the neovascularization in order to 
restore the tissue health and integrity. Apart from this 
the pharmacological active constituents also count and 
bacterial and fungal growth also. The principle of 
cauterization is, it breaks up fibrosis, promotes 
granulation and new tissue formation at the margin of 
the perforation. The patch acts as a splint to bridge the 
margins of the perforation and give flat surface. 
 Histopathological examination of the 
granulation tissues in the A. aspera treated animals 
showed collagen deposition, fibroblast proliferation and 
formation of epidermis which probably can explain the 
successful outcome of the present trial and suggesting 
Apamarga Kshara as an effective and safe substitute to 
Trichloroacetic acid cauterization.20 
 Genistein is a phytoestrogen isoflavone that is 
found abundantly in A. aspera. Genistein has known 
anthelmintic, antioxidant properties and has been shown 
to interact with animal and human estrogen receptors. 
Apart from these properties, genistein has tyrosine 
kinase inhibitory activity mostly of the epidermal growth 
factor receptor (EGFR)21. The reason why traumatic 
perforation has got a 100% closure observed in both the 
groups can be explained by the fact that traumatic 
perforations being sterile one in almost all of the cases 
and these slit like perforation has got less margin to 
margin distance and the neo generated membrane as a 
result of cauterization has relatively less distance to 
cover in order to re approximate and complete the 
tympanic membrane anatomy. Pathological perforations 
on the other hand have got an intermittently discharging 
and an active middle ear mucosa which time and again 
evert/expedite the healing tympanic membrane margins 
making it difficult to restore the surface itself. Hearing 
loss was effectively reduced to less than 20 db 
(audiometric average of 500, 1000 and 200 Hz in PTA) in 
both the trail groups because of resurfacing and hence 
increase in the effective vibratory area of the tympanic 
membrane and round window shielding effect.  
CONCLUSION 
 Removal of this medialized epithelium, 
freshening of the perforation margins and prevention of 
recurrent infection of the cauterized tissue forms the 
basis of tympanic membrane re-epithelialization which is 
well taken care of by application of A. aspera alkaline 
extract. A. aspera alkaline extract breaks the submucosal 
fibrosis, excessive necrosed tissue and augments the 
neovascularization in order to restore the integrity of a 
perforated tympanic membrane. A. aspera alkaline 
extract can safely advocated as an Ayurvedic 
cauterization substitute for the resurfacing of the 
ruptured tympanic membrane with a successful closure 
rate of 83.3% in comparison to 87.5%, which is observed 
in trichloroacetic acid, traditionally used as a chemical 
myringoplasty agent. 
REFRENCES 
1. Shambaugh surgery of the ear. 5th ed. Spain: BC 
Decker Inc; 2003. p. 400–420. 
2. N. C. Goldman. Chemical Closure of Chronic 
Tympanic Membrane Perforations. ANZ Journal of 
Surgery.2007; 77: 850-851. 
3. K. S. Uppal, et al. Closure of Tympanic Membrane 
Perforations by Chemical Cautery. IJO & HNS.1997; 
49: 151-153.  
4. Marra S, et al. Effectiveness of non surgical closure 
of tympanic membrane pars tensa perforation. Ear 
Nose Throat J.2002; 81(8): 556–558.  
5. Raj Neeta S., Jyoti B., Anjuvan S., Prabhjot K. 
Antibacterial potential of Achyranthus aspera Linn 
Procured from Himachal Pradesh, Punjab and 
Haryana, India. Res. J. Chem. Sci.2011; 1: 80–82.  
6. Luseba D., Elgorashi E. E., Ntloedibe D. T., Van 
Staden J. Antibacterial, anti-inflammatory and 
mutagenic effects of some medicinal plants used in 
South Africa for treatment of wounds and retained 
placenta in livestock. S. Afr. J. Bot.2007; 73: 378–
383. 
7. Fikru A, Makonnen E, Eguale T, Debella A, Abie 
Mekonnen G. Evaluation of in vivo wound healing 
activity of methanol extract of Achyranthes aspera 
L. J Ethnopharmacol.2012; 143(2): 469-74. 
8. Ghosh PK, Gaba A. Phyto-extracts in wound 
healing. J Pharm Pharm Sci.2013; 16(5): 760-820.  
9. Barua CC, Archana Talukdar, Begum SA, Pathak DC, 
Sarma DK, Borah RS, Asheesh Gupta. In vivo 
wound-healing efficacy and antioxidant activity of 
Achyranthes aspera in experimental burns. 
Pharmaceutical Biology.2012; 50(7): 892-899. 
10. Gangopadhyay KS, Khan M, Pandit S, Chakrabarti S, 
Mondal TK, Biswas TK. Pharmacological evaluation 
and chemical standardization of an ayurvedic 
formulation for wound healing activity. Int J. Low 
Extrem Wounds.2014; 13(1): 41-49. 
11. Browning GG, Gatehouse S. The prevalence of 
middle ear disease in the adult British population. 
Clin Otolaryngol.1992; 17: 317–21. 
12. W. R. Wilde and A. Hewson. Practical Observations 
on Aural Surgery and the Nature and Treatment of 
Diseases of the Ear. Blanchard & Lea, Philadelphia, 
1853, pp. 292-293. 
13. Derlacki EL. Repair of central perforations of 
Int. J. Ayur. Pharma Research, 2016;4(1):16-22 
 IJAPR | January 2016 | Vol 4 | Issue 1   21 
tympanic membrane. Arch Otolaryngol. 1953; 58: 
405-409. 
14. Derlacki EL. Residual perforations after 
tympanoplasty: office technique for closure. 
Otolaryngol Clin North Am.1982; 15: 861-867.  
15. Derlacki EL. Office Closure of Central Tympanic 
Membrane Perforation: A Quarter Century 
Experience. Transactions of the American 
Academy of Ophthalmology.1973; 77: 53-56. 
16. Taylor M. McMinn RM. Healing of experimental 
perforations of the tympanic membrane. J. 
Laryngol Otol.1965; 79: 148-152. 
17. Gladstone HB, Jackler RK, Varav K. Tympanic 
membrane wound healing - An overview. 
Otolaryngol Clin North Am.1995; 28: 913–32.  
18. Yamashita T. Histology of the tympanic perforation 
and the replacement membrane. Acta Otolaryngol 
(Stockh.).1985; 100: 66–71.  
19. T. S. Dudhamal, S. K. Gupta, Chaturbhuj Bhuyan, 
Kulwant Singh. The role of Apamarga Kshara in the 
treatment of Arsha. Ayu.2010; 31(2): 232–235.  
20. Chandana Choudhury Baruaa, Archana Talukdara, 
Shameem Ara Beguma, Debesh Chandra Pathaka, 
Dilip Kumar Sarmaa, Rumi Saikia Boraha & 
Asheesh Gupta. in vivo wound-healing efficacy and 
antioxidant activity of Achyranthes aspera in 
experimental burns. Pharmaceutical Biology.2012; 
50: 76-82. 
21. Tandon V, Das B, Saha N. Anthelmintic efficacy of 
Flemingia vestita (Fabaceae): Effect of genistein on 
glycogen metabolism in the cestode, Raillietina 
echinobothrida. Parasitol Int. 2003; 52(2): 179-8. 
 
  
Cite this article as:  
Atul Bhardwaj, Riju Agarwal, Manoj Tanwar, Anoop Kumar. Clinical 
Comparison of Tympanic Membrane Perforation Closure with Trichloroacetic 
Acid and Apamarga Kshara (Achyranthes Aspera Linn. Alkaline Extract). 
International Journal of Ayurveda and Pharma Research. 2016;4(1):16-22. 
Source of support: Nil, Conflict of interest: None Declared 
 
*Address for correspondence 
Dr. Atul Bhardwaj 
Assistant Professor  
Dept. of Shalakya Tantra 
Chaudhary Brahm Prakash 
Ayurveda Charak Sansthan,  
New Delhi, India. 
Mob: 09818037916 
Email: dratulbhardwaj@gmail.com 
Atul Bhardwaj et al. Tympanic Membrane Perforation Closure with Trichloroacetic Acid and Apamarga Kshara  
 Available online at: http://ijapr.in  22 
Tables and column charts 
Column chart 1: Attributes of perforation in two groups 
  
Table 2: Clinical data expression in TCAG 
Total no. of application in TCAG for closure 
of tympanic membrane 
No. of cases  Average no. of applications in TCAG 
1 1  
 
3.07 
  
2 3 
3 6 
4 2 
5 2 
Non healing/healing failure 2 
Table 3: Clinical data expression in APKG 
Total no. of application in APKG for closure of 
tympanic membrane 
No. of cases  Average no. of applications in APKG 
1 0  
 
3.26 
  
2 4 
3 6 
4 2 
5 3 
Non healing/healing failure 3 
Table 4: Comparative clinical outcome in hearing loss in TCAG and APKG 
Attributes TCAG APKG 
Total no. of patients 16 18 
Perforation size < 3 mm  7 8 
Perforation size 3-5 mm 9 10 
Audiometric average (average of 500,100 and 2000 Hz in PTA) hearing loss before Trial 36db 38db 
Audiometric average (average of 500,100 and 2000 Hz in PTA) hearing after before Trial 17db 18db 
Column chart 2: Comparison of successfully closed Tympanic membrane in both groups 
 
0
5
10
15
TCAG APKG
unilateral perforation
bilateral perforation
pathological perforation
traumatic perforation
no. of patients
residual perforation
% of traumatic perforation healed
0
50
100
TCAG APKG
no. of patients
% successfully closed
residual perforation
discharging ear
